Bali GLP-1 buyer's guide 2026: BIMC, Body Tonic, Siloam scored honestly

Bali built the only nomad-aimed clinic layer in expat Southeast Asia. Body Tonic Clinic in Canggu, Cocoon Medical Spa in Seminyak, and the international hospital network anchored by BIMC have all leaned into the cash-pay, Stripe-friendly, English-first cohort that Bali attracts. The catch is BPOM. In late 2025, Indonesian customs tightened import enforcement on GLP-1 medication, and supply has been intermittent ever since. Add to that the grey-market peptide menu (BPC-157, TB-500) that some clinics bundle around GLP-1, and the picking-the-right-route question becomes more important than the picking-the-right-price question.

This guide covers the four expat-routable Bali providers, what is actually being sold, the BPOM posture, and how to pick.

What is actually being sold

Two medications are in mainstream Bali private prescription circulation: tirzepatide (brand Mounjaro) and semaglutide (brand Ozempic). Wegovy distribution into Indonesia is sporadic. Saxenda is rare. Tirzepatide became the dominant cash-pay choice in 2025, then the late-2025 import tightening made supply intermittent across both Mounjaro and Ozempic.

What you are paying for, on a Bali private Rx, is some combination of:

1. The pen itself (BPOM-registered import; Eli Lilly Indonesia or Novo Nordisk Indonesia) 2. A prescription from a licensed Indonesian doctor 3. Cold-chain handling (international hospitals do this reliably; nomad clinics vary) 4. The wraparound layer: international hospital insurance billing, nomad clinic Stripe-pay, or aesthetic-spa positioning

The variance in those four components is where the USD 220 to USD 920 monthly range comes from. Importantly, two clinics in the nomad layer also offer a peptide menu (BPC-157, TB-500, sometimes others) alongside GLP-1. That peptide menu is grey-market under BPOM, not registered, and Panya does not route there. The GLP-1 consult at those clinics is BPOM-channel and routable; the peptide menu is not.

Per-month pricing across the market, April 2026

Bali GLP-1 is priced per month rather than dose-step, mostly in USD because the customer base is international. We pulled the public pages and intake-line numbers and normalised to a typical maintenance month at common doses.

Provider	Areas	Monthly USD	Notes

| BIMC Hospital | Kuta, Nusa Dua | 220 to 480 | Australian-affiliated, intl insurance, the BPOM-default expat anchor. | | Siloam Hospitals Bali | Denpasar | 220 to 460 | Largest legitimate BPOM-channel pharma supply. Less consumer-marketing. | | Kasih Ibu | Denpasar, Saba | 240 to 500 | Indonesian premium hospital chain, BPOM-channel. | | Body Tonic Clinic | Canggu | 340 to 920 | Nomad clinic, Stripe + crypto. GLP-1 consult only — not the peptide menu. | | Cocoon Medical Spa | Seminyak | 380 to 880 | Aesthetic-first nomad clinic. Confirm BPOM channel at intake. |

Numbers are accurate as of April 2026. Most providers absorb cold-chain in the monthly figure. International insurance (Cigna, BUPA, Allianz Care) direct-bills at BIMC; Siloam and Kasih Ibu accept it but the workflow is slower. Body Tonic and Cocoon are cash-pay only.

What our 11-signal rubric scores them on

Our rubric is public. Eleven signals, each scored 0 to 100. Below is how we scored the Bali expat anchors.

BIMC Hospital — 71/100. Strongest Bali score in our audit. Australian-affiliated, around 25 years on the island, intl insurance direct billing. The BPOM-default for cohort-7 routing. Lost points on price transparency (published pricing thin) and on supply continuity since the late-2025 import tightening. Routable as the expat anchor.

Body Tonic Clinic — 69/100, conditional. Built explicitly for the Canggu nomad demographic. Stripe + crypto payments, English-first intake, GLP-1 consult via partner MD. Clean for the GLP-1 consult track. The conditional flag: their peptide menu (BPC-157, TB-500) sits grey-market under BPOM and Panya does not route there. We surface this in the match email so the user knows what they are and are not buying. Routable for GLP-1 consult only.

We did not score Siloam or Kasih Ibu in this audit round because the consumer-facing operations are Indonesian-first and the English-fluency depth is uneven. They are real legitimate options for users who want the lowest BPOM-channel cost; we will revisit by Q3 2026 when we have a cleaner cohort-7 testing flow.

We did not score Cocoon because the aesthetic-spa framing made the metabolic indication unclear in our audit. They are a credible aesthetic clinic and the GLP-1 consult is real, but the routing flow is opaque.

Regulatory posture you should know about

Bali GLP-1 is overseen by BPOM (Badan Pengawas Obat dan Makanan) for medication registration and the Indonesian Ministry of Health for clinical practice. Mounjaro and Ozempic are BPOM-registered for diabetes; the off-label use for weight management is allowed but the supply chain runs through diabetes-allocated stock.

The defining event was late-2025 BPOM import tightening. The agency increased customs scrutiny on GLP-1 personal-import shipments and forced more allocation through licensed hospital channels rather than direct-to-consumer pharmacy. Practical effect:

1. Nomad clinics that previously sourced from grey channels lost that path. They now source from BPOM-licensed pharmacies, which is good for compliance but constrains supply. 2. Personal carry-in by visitors hitting customs has increased risk. Anything more than personal-use quantity is flagged. 3. Supply is intermittent at every level. Even BIMC and Siloam run dry occasionally.

The grey-market peptide layer (BPC-157, TB-500, sometimes thymosin alpha-1) has expanded in some Canggu nomad clinics. These are not BPOM-registered. Panya does not route to peptide menus. Other clinics may; we are explicit that we do not.

If a Bali provider you are considering is not BPOM-licensed (verifiable via the BPOM register), do not enrol. The list is finite and it is the floor.

How to pick

The decision tree we use when matching:

You want the default expat anchor with intl insurance. BIMC Hospital. USD 220 to 480 per month, BPOM-channel supply, Australian-affiliated clinical posture.

You are nomad-cohort in Canggu. Body Tonic Clinic. USD 340 to 920 per month, Stripe and crypto pay, English-first. GLP-1 consult only — Panya routes you for the consult and flags the peptide menu as out of scope.

You want the lowest BPOM-channel cost. Siloam Hospitals Bali (Denpasar). USD 220 to 460 per month. The clinical depth is real but the consumer flow is built for Indonesian-language patients.

You are based in north or east Bali. Kasih Ibu. USD 240 to 500 per month, multiple locations, BPOM-channel.

You want the cheapest path. USD 220 per month is the practical floor for expat-grade BPOM-channel routing. Anything below that, ask harder about supply provenance.

What we will not tell you is which one is "best." There is no single best; the supply intermittency since late-2025 reshuffles the answer monthly. The match email Panya sends names the specific provider for your dose, location, and budget, and confirms current BPOM-channel supply before routing.

What we are not covering here

Personal carry-in from Australia, Singapore, or Thailand. A common nomad pattern is to source GLP-1 in Bangkok or Singapore on visit days and carry into Bali. Customs enforcement increased in late 2025 and the personal-import threshold is enforced. We do not route here.

Online pharmacies that ship into Bali from outside Indonesia. A few cross-border telehealth providers will ship from Australia or the Philippines. We do not route here because the legal posture is fuzzy and the cold-chain on a 6 to 12 hour transit is real.

Peptide menus (BPC-157, TB-500, thymosin alpha-1, ipamorelin, CJC-1295). These appear at some Canggu nomad clinics alongside GLP-1. They are grey-market under BPOM and we do not route there. The match email is explicit about this when the user asks about peptides at a Bali clinic.

Sources we audited against

• BPOM registration database, April 2026
• BPOM late-2025 import-enforcement bulletin
• Each provider's published pricing and intake page (April 2026)
• Cohort-7 outreach research, internal
• International insurance direct-bill verification (Cigna, BUPA, Allianz Care)

Updated April 2026. We refresh quarterly. Last updated 2026-04-26.

If you spot a number that has shifted or a provider we have miscategorised, email partner@panya.health and we will check the source and update the page with a public changelog.